Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Zhiwei Zheng

Biographic Data

ID7527394
NAMEZhiwei Zheng
GIVEN NAMESZhiwei
FAMILY NAMEZheng
SIGNATUREZHENG Z
AFFILIATIONSShantou University
ORCID0000-0002-8205-420X
VERIFIEDYes
TOTAL WORKS10
TOTAL CITATIONS0
AUTHOR COUNT10
EDITOR COUNT0
FIRST PUBLICATION YEAR2013
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Cost-effectiveness analysis of cadonilimab plus chemotherapy as a first-line treatment option in HER-2-negative advanced gastric cancer

    Open Access•Longfeng Zhang, Qingsheng Yang et al.•ARTICLE•Frontiers in Public Health•2025

    Objective: This study aims to evaluate the cost-effectiveness of using cadonilimab plus chemotherapy compared to chemotherapy in HER-2-negative advanced gastric cancer from the perspective of the Chinese healthcare system. Methods: A cost-effectiveness analysis was conducted utilizing a partitioned survival model to simulate the expected costs and outcomes associated with the treatment of patients with cadonilimab in combination with chemotherapy…

  • Toripalimab plus chemotherapy in the treatment of metastatic triple-negative breast cancer

    Open Access•Hongfu Cai, Lisheng Huang et al.•ARTICLE•Frontiers in Public Health•2024

    Objective: This study focuses on assessing the cost-effectiveness of incorporating toripalimab alongside chemotherapy for the treatment of patients diagnosed with metastatic triple-negative breast cancer from the perspective of the Chinese healthcare system. Methods: A partitioned survival model was constructed to simulate the costs and health outcomes over the lifetime of patients with mTNBC. Clinical data regarding overall survival, progression…

  • Tislelizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma in China

    Open Access•Zhiwei Zheng, Yuxuan Lin et al.•ARTICLE•Frontiers in Public Health•2024

    Objective: The goal of this study is to compare the cost-effectiveness of tislelizumab and sorafenib as first-line treatment for advanced hepatocellular carcinoma in China. Methods: A comprehensive cost-effectiveness analysis was undertaken within the framework of a partitioned survival model to accurately gage the incremental cost-effectiveness ratio (ICER) of tislelizumab compared to sorafenib. The model incorporated relevant clinical data and …

  • Experiences in promoting the development of suburban edible landscapes through place branding

    Open Access•Zhi-Wei Zheng, Zhiwei Zheng et al.•ARTICLE•Cities•2024•References: 64

  • Multimorbidity patterns, social networks, and depression among chinese older women

    Open Access•Yuexuan Mu, Zhiwei Zheng•ARTICLE•Current Psychology•2023

  • Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy vs. Chemotherapy Alone as First-Line Treatment in Patients With Esophageal Squamous Cell Carcinoma and PD-L1 CPS of 10 or More

    Open Access•Zhiwei Zheng, Jingrong Lin et al.•ARTICLE•Frontiers in Public Health•2022

    Background: This study aimed to analyze the economics of pembrolizumab plus chemotherapy as first-line treatment in patients with esophageal squamous cell carcinoma (ESCC) and programmed cell death-Ligand 1 (PD-L1) combined positive score (CPS) of 10 or more in China. Methods: Based on the advanced ESCC of the KEYNOTE-590 clinical trial data, a Markov model was performed to simulate the clinical course and evaluate the patient's total lifetime, t…

  • Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia

    Open Access•Lijuan Huo, Zhiwei Zheng et al.•ARTICLE•Frontiers in Psychiatry•2021

    Objectives: There are relatively few studies on mechanisms of cognitive deficits in late-life schizophrenia (LLS). Brain-derived neurotrophic factor (BDNF), as an important neuroplastic molecule, has been reported to be involved in neurocognitive impairment in schizophrenia. This study aimed to examine whether peripheral BDNF levels were associated with cognitive deficits in LLS, which has not been explored yet. Methods: Forty-eight LLS patients …

  • Effects of Transcranial Direct Current Stimulation on Episodic Memory in Older Adults

    Open Access•Lijuan Huo, Xinyi Zhu et al.•ARTICLE•The Journals of Gerontology…•2021

  • A Randomized Controlled Trial Evaluating Efficacy of a Brief Setting-Based and Theory-Based Intervention Promoting Voluntary Medical Male Circumcision Among Heterosexual Male Sexually Transmitted Dise…

    Open Access•Johnson Zixin Wang, Ligang Yang et al.•ARTICLE•AIDS and Behavior•2019

  • Emotional Prosody Modulates the Recognition of Affective Word

    Zhiwei Zheng, Xianjun Huang et al.•ARTICLE•Acta Psychologica Sinica•2013

    摘要: 采用韵律/词汇干扰范式和延迟匹配任务, 通过两个ERP实验, 考察了汉语口语中情绪韵律能否、以及如何调节情绪词的识别。实验一中, 不同类型的情绪韵律分组呈现, ERP结果显示, 同与情绪韵律效价一致的情绪词相比, 与情绪韵律效价不一致的情绪词诱发了走向更负的P200、N300和N400成分; 实验二中, 不同类型的情绪韵律随机呈现, 上述效价一致性效应依然存在。实验结果表明, 情绪韵律能够调节情绪词识别, 主要表现在对情绪词的音韵编码和语义加工的双重易化上

No prominent works on this page.

  • Emotional Prosody Modulates the Recognition of Affective Word

    Zhiwei Zheng, Xianjun Huang et al.•ARTICLE•Acta Psychologica Sinica•2013

    摘要: 采用韵律/词汇干扰范式和延迟匹配任务, 通过两个ERP实验, 考察了汉语口语中情绪韵律能否、以及如何调节情绪词的识别。实验一中, 不同类型的情绪韵律分组呈现, ERP结果显示, 同与情绪韵律效价一致的情绪词相比, 与情绪韵律效价不一致的情绪词诱发了走向更负的P200、N300和N400成分; 实验二中, 不同类型的情绪韵律随机呈现, 上述效价一致性效应依然存在。实验结果表明, 情绪韵律能够调节情绪词识别, 主要表现在对情绪词的音韵编码和语义加工的双重易化上

  • A Randomized Controlled Trial Evaluating Efficacy of a Brief Setting-Based and Theory-Based Intervention Promoting Voluntary Medical Male Circumcision Among Heterosexual Male Sexually Transmitted Dise…

    Open Access•Johnson Zixin Wang, Ligang Yang et al.•ARTICLE•AIDS and Behavior•2019

  • Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia

    Open Access•Lijuan Huo, Zhiwei Zheng et al.•ARTICLE•Frontiers in Psychiatry•2021

    Objectives: There are relatively few studies on mechanisms of cognitive deficits in late-life schizophrenia (LLS). Brain-derived neurotrophic factor (BDNF), as an important neuroplastic molecule, has been reported to be involved in neurocognitive impairment in schizophrenia. This study aimed to examine whether peripheral BDNF levels were associated with cognitive deficits in LLS, which has not been explored yet. Methods: Forty-eight LLS patients …

  • Effects of Transcranial Direct Current Stimulation on Episodic Memory in Older Adults

    Open Access•Lijuan Huo, Xinyi Zhu et al.•ARTICLE•The Journals of Gerontology…•2021

  • Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy vs. Chemotherapy Alone as First-Line Treatment in Patients With Esophageal Squamous Cell Carcinoma and PD-L1 CPS of 10 or More

    Open Access•Zhiwei Zheng, Jingrong Lin et al.•ARTICLE•Frontiers in Public Health•2022

    Background: This study aimed to analyze the economics of pembrolizumab plus chemotherapy as first-line treatment in patients with esophageal squamous cell carcinoma (ESCC) and programmed cell death-Ligand 1 (PD-L1) combined positive score (CPS) of 10 or more in China. Methods: Based on the advanced ESCC of the KEYNOTE-590 clinical trial data, a Markov model was performed to simulate the clinical course and evaluate the patient's total lifetime, t…

  • Multimorbidity patterns, social networks, and depression among chinese older women

    Open Access•Yuexuan Mu, Zhiwei Zheng•ARTICLE•Current Psychology•2023

  • Toripalimab plus chemotherapy in the treatment of metastatic triple-negative breast cancer

    Open Access•Hongfu Cai, Lisheng Huang et al.•ARTICLE•Frontiers in Public Health•2024

    Objective: This study focuses on assessing the cost-effectiveness of incorporating toripalimab alongside chemotherapy for the treatment of patients diagnosed with metastatic triple-negative breast cancer from the perspective of the Chinese healthcare system. Methods: A partitioned survival model was constructed to simulate the costs and health outcomes over the lifetime of patients with mTNBC. Clinical data regarding overall survival, progression…

  • Tislelizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma in China

    Open Access•Zhiwei Zheng, Yuxuan Lin et al.•ARTICLE•Frontiers in Public Health•2024

    Objective: The goal of this study is to compare the cost-effectiveness of tislelizumab and sorafenib as first-line treatment for advanced hepatocellular carcinoma in China. Methods: A comprehensive cost-effectiveness analysis was undertaken within the framework of a partitioned survival model to accurately gage the incremental cost-effectiveness ratio (ICER) of tislelizumab compared to sorafenib. The model incorporated relevant clinical data and …

  • Experiences in promoting the development of suburban edible landscapes through place branding

    Open Access•Zhi-Wei Zheng, Zhiwei Zheng et al.•ARTICLE•Cities•2024•References: 64

  • Cost-effectiveness analysis of cadonilimab plus chemotherapy as a first-line treatment option in HER-2-negative advanced gastric cancer

    Open Access•Longfeng Zhang, Qingsheng Yang et al.•ARTICLE•Frontiers in Public Health•2025

    Objective: This study aims to evaluate the cost-effectiveness of using cadonilimab plus chemotherapy compared to chemotherapy in HER-2-negative advanced gastric cancer from the perspective of the Chinese healthcare system. Methods: A cost-effectiveness analysis was conducted utilizing a partitioned survival model to simulate the expected costs and outcomes associated with the treatment of patients with cadonilimab in combination with chemotherapy…

Medicine (7 works) · Internal Medicine (6 works) · Oncology (4 works) · Cancer (3 works) · Chemotherapy (3 works) · Economic and Financial Impacts of Cancer (3 works) · Psychiatry (3 works) · Psychology (3 works) · Cancer Immunotherapy and Biomarkers (2 works) · Cost effectiveness (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae